Stocks and Investing
Stocks and Investing
Mon, June 24, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, June 21, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Whitney Ijem Maintained (ALNY) at Strong Buy and Held Target at $283 on, Jun 21st, 2024
Whitney Ijem of Canaccord Genuity, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $283 on, Jun 21st, 2024.
Whitney has made no other calls on ALNY in the last 4 months.
There are 6 other peers that have a rating on ALNY. Out of the 6 peers that are also analyzing ALNY, 1 agrees with Whitney's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Olivia Brayer of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $150 on, Friday, February 23rd, 2024
These are the ratings of the 5 analyists that currently disagree with Whitney
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $400 on, Tuesday, May 7th, 2024
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $200 on, Thursday, May 2nd, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Wednesday, March 27th, 2024
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $235 on, Wednesday, February 21st, 2024
Contributing Sources